Results 21 to 30 of about 62,609,046 (216)

Torsades de Pointes Triggered by Transient Low‐Rate Pacing Following Leadless Pacemaker Implantation [PDF]

open access: yesJournal of Arrhythmia
Yumetsugu Munakata   +4 more
doaj   +2 more sources

Ephedrine‐Triggered Torsades de Pointes in Two Patients Following Desflurane‐Induced QT Prolongation [PDF]

open access: yesJournal of Arrhythmia
Shinichi Harada   +4 more
doaj   +2 more sources

Idiopathic short-coupled ventricular tachyarrhythmias: Systematic review and validation of electrocardiographic indices

open access: yesThe Egyptian Heart Journal, 2018
Introduction: Idiopathic short-coupled ventricular tachyarrhythmias make up a considerable proportion of ventricular tachyarrhythmias in structurally normal hearts and are the cause of 5–10% of unexpected sudden cardiac deaths.
Mohammed Almehairi   +2 more
doaj   +1 more source

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]

open access: yes, 2013
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
MORETTI, Ugo   +38 more
core   +1 more source

Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes

open access: yesClinics and Practice, 2021
There are several classes of medications that can cause prolongation of the corrected QT (QTc) interval and potentially Torsades de Pointes (TdP). Most of these medications are commonly used in the emergency department, and interaction between these ...
Karthik Gnanapandithan   +2 more
doaj   +1 more source

Torsade de pointes [PDF]

open access: yesClinical Cardiology, 1993
AbstractThe polymorphic ventricular tachycardia torsade de pointes can occur in the congenital long QT syndromes or as a consequence of therapy with QT‐prolonging drugs. The latter can include not only antiarrhythmic drugs such as quinidine, but also a number of drugs which are not usually considered to have major cardiovascular effects: these include ...
openaire   +2 more sources

Ondansetron induced torsades de pointes

open access: yesClinical Case Reports, 2019
A single dose of oral Ondansetron can precipitate torsades de pointes and other arrhythmias in patients with risk factors that may prolong QTc interval.
Eshan Patel   +2 more
doaj   +1 more source

Case report: Ivabradine induced Torsades de Pointes

open access: yesIHJ Cardiovascular Case Reports, 2023
Ivabradine is used to control heart rate in patients of heart failure with reduced ejection fraction. Although considered safe, it is reported to prolong QTc interval when given with other QTc prolonging drugs or in setting of hypokalemia or ...
Mohit M. Bhagwati   +2 more
doaj   +1 more source

HALOPERIDOL-INDUCED TORSADES DE POINTES: A CASE REPORT

open access: yes, 2020
Torsades de pointes (Tdp) is a malignant polymorphic ventricular arrhythmia1 often associated with drugs like haloperidol that prolonged QTc interval2. If enough care is not taken this may lead to sudden death.
JAVED ATHER SIDDIQUI (8442636)
core   +2 more sources

Pharmacological and therapeutical basis of torsades de pointes [PDF]

open access: yes, 2017
Torsades de pointes (TdP) is a specific form of polymorphic ventricular tachycardia, which is a dreadful condition, severity varies from mild asymptomatic condition to severe life threatening state.
Pakanati, Vijayakrishna   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy